The stated rationale was safety concerns, though many clinicians and compounding pharmacy groups argued the agency overstepped, noting that no specific safety signal justified the restriction for most of the affected peptides
Severe gastrointestinal disease: Do not use if you have a history of severe gastrointestinal disorders such as gastroparesis
Individuals in the semaglutide treatment group lost, on average, 14.9% of their body weight compared to baseline
[45] In a large prospective cohort study in the US (the Health Professionals Follow-up Study), investigators reported modest associations between BPH (men with strong symptoms of BPH or surgically confirmed BPH) and total energy and protein, but not fat intake
Injections may be administered at a healthcare facility or at home
Long-term (ongoing maintenance): Regular IVs can lead to more even skin tone and a steady reduction in signs of aging